Deal Type

UK-based Epsilogen, a developer of immunoglobulin E (IgE) antibody therapeutics, has completed the acquisition of US-based TigaTx, a biotech company developing engineered immunoglobulin A...

UK-headquartered Investindustrial, a European independent investment group, has held a final closing of its latest fund, Investindustrial VIII, with €4bn in commitments, exceeding its...

In March, France-based healthcare investment firm Mérieux Equity Partners (MxEP) acquired a majority stake in curea Medical, a carve-out from McAirlaid’s, a global producer...

Kvika, the UK subsidiary of Iceland-based Kvika banki, has closed HCPII Fund, surpassing its target with backing from new and existing investors across Iceland...

Affidea, a pan-European provider of specialist healthcare services including cancer care, advanced diagnostic imaging and community-based polyclinics, has doubled its size in Switzerland with...

Nasdaq-listed MoonLake Immunotherapeutics, a Switzerland-based clinical-stage biotech company focused on creating next-level therapies for inflammatory diseases, has entered into an agreement with Hercules Capital,...

Oakley Capital, a pan-European private equity investor, announced the final close of Oakley Capital VI at its €4.5bn (US$4.95bn) hard cap at the end...

GHO Capital portfolio company Eliquent Life Sciences, a US-headquartered quality, compliance and regulatory affairs consulting firm, has acquired Truliant Consulting, a US-headquartered pharmacovigilance, risk...

India-based global pharma Lupin is acquiring Renascience Pharma, a UK-based pharmaceutical company that aims to meet clinical need through the revival of forgotten critical...

Imagine Human, a France-based software publisher focused on health, safety, and quality of life at work, is acquiring Saphir Consult and its SaaS solution...